Empathic Communication Skills Training to Reduce Lung Cancer Stigma
Empathic Communication Skills Training to Reduce Lung Cancer Stigma
Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma within clinical encounters; however, no formal trainings exist that focus on teaching empathic communication to oncology care providers (OCPs). Building upon favorable findings from a prior R21 (R21CA202793) and the importance of developing interventions to address lung cancer stigma, our goal is to conduct a national trial of empathic communication skills (ECS) training to facilitate improvements in the medical and psychosocial care of patients through de-stigmatizing interactions with OCPs for patients diagnosed with lung cancer.
The aims of this study are:
to evaluate the effect of the ECS training on OCP primary outcomes (communication and empathic skill uptake) and secondary outcomes (ECS training appraisal - relevance, novelty, clarity; self-efficacy, empathy, compassion burn-out);
to evaluate the effect of the ECS training vs. WLC on patients' reported primary outcomes (lung cancer stigma), and secondary outcomes (perceived clinician empathy, satisfaction with communication, psychological distress, patients' experience of clinical encounter, and overall patient satisfaction).
Additionally, acceptance of referral to tobacco cessation (for those currently smoking) will be explored; and
to examine potential moderators of OCP (e.g., demographic characteristics, professional role characteristics) and patient outcomes (e.g., demographic characteristics, illness characteristics).
Our central hypothesis is that the ECS training will demonstrate significant short-term improvements in clinicians' uptake of empathic skills and self-efficacy and will be superior to WLC with regards to patient reported measures of stigma, clinician empathy, satisfaction, and overall experience.
Inclusion Criteria:
Site Eligibility
OCP Participant Eligibility
Patient Eligibility
Patient under the care of a participating OCP as per self report;
English and/or Spanish speaking;
Is at least 18 years of age as per self report;
Has a history of suspicious lung mass or confirmed lung cancer diagnosis, as per clinician judgment or medical record note;
Is a former or current smoking as per self report;
Has had no more than 10 prior visits with the participating OCP, as per the medical record and/or self report
Exclusion Criteria:
Patient Exclusion
Site and OCP Exclusion
banerjes@mskcc.org646-888-0011
ostroffj@mskcc.org646-888-0041
Miami, Florida 33143, United States
786-596-2000
Hackensack, New Jersey 07601, United States
Buffalo, New York 14263-0001, United States
New York, New York 10065, United States
Philadelphia, Pennsylvania 19104-4283, United States
Philadelphia, Pennsylvania 19111, United States
847-367-6781
551-996-8704
716-845-2300
646-888-0011
(215) 615-5858
215-728-4066
757-842-4499